atezolizumab
Showing 26 - 50 of 400
Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial (biological, procedure, drug)
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- Refractory Malignant Solid Neoplasm
- Atezolizumab
- +5 more
- (no location specified)
Feb 4, 2023
Hepatocellular Carcinoma Trial in Guangzhou (Atezolizumab, Bevacizumab, HAIC with FOLFOX)
Recruiting
- Hepatocellular Carcinoma
- Atezolizumab
- +2 more
-
Guangzhou, Guangdong, ChinaCancer Center Sun Yat-sen University
May 24, 2023
Idiopathic Pulmonary Fibrosis Trial in Los Angeles (Atezolizumab)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- Atezolizumab
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Aug 23, 2022
Hepatocellular Carcinoma, NSCLC Metastatic, Liver Metastases Trial in Toronto (Atezolizumab, Bevacizumab)
Recruiting
- Hepatocellular Carcinoma
- +2 more
- Atezolizumab
- Bevacizumab
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jan 8, 2023
Endometrial Cancer Trial in Birmingham, Saint Louis, Oklahoma City (Bevacizumab, Atezolizumab)
Active, not recruiting
- Endometrial Cancer
- Bevacizumab
- Atezolizumab
-
Birmingham, Alabama
- +2 more
Nov 21, 2022
Solid Tumor Trial in Dallas (Atezolizumab, Vincristine, Irinotecan)
Not yet recruiting
- Solid Tumor
- Atezolizumab
- +3 more
-
Dallas, TexasThe University of Texas Southwestern Medical Center
Aug 30, 2022
Malignant Pleural Mesothelioma Trial in Edegem, Ghent, Sint-Niklaas (Dendritic cell vaccination, Atezolizumab,
Not yet recruiting
- Malignant Pleural Mesothelioma
- Dendritic cell vaccination
- +2 more
-
Edegem, Antwerp, Belgium
- +2 more
Feb 28, 2023
Breast Cancer Trial in Boston (Atezolizumab, Stereotactic radiosurgery (SRS))
Active, not recruiting
- Breast Cancer
- Atezolizumab
- Stereotactic radiosurgery (SRS)
-
Boston, MassachusettsDana-Farber Cancer Institute
Aug 15, 2022
Hepatocellular Carcinoma Trial in Tampa (Selinexor Pill, Bevacizumab, Atezolizumab)
Recruiting
- Hepatocellular Carcinoma
- Selinexor Pill
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
Aug 16, 2022
Lung Cancer, NSCLC Stage IV, Metastatic NSCLC - NSCLC Trial in Kansas City, Overland Park, Lee's Summit (Cabozantinib,
Not yet recruiting
- Lung Cancer
- +3 more
- Cabozantinib
- Atezolizumab
-
Kansas City, Kansas
- +3 more
May 12, 2023
Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in Houston (drug, behavioral, radiation)
Not yet recruiting
- Squamous Cell Carcinoma
- Oral Cavity Squamous Cell Carcinoma
- Tiragolumab
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jan 27, 2023
Hepatocellular Carcinoma Trial in United States (Y-90 TARE, Atezolizumab, Bevacizumab)
Recruiting
- Hepatocellular Carcinoma
- Y-90 TARE
- +2 more
-
Washington, District of Columbia
- +5 more
Jan 18, 2023
Gastrointestinal Cancer Trial in New York, Providence (Cobimetinib, Hydroxychloroquine, Atezolizumab)
Active, not recruiting
- Gastrointestinal Cancer
- Cobimetinib
- +2 more
-
New York, New York
- +1 more
Nov 29, 2022
Rectal Tumors Trial in Belgium (Atezolizumab, 5-FU based radio-chemo)
Recruiting
- Rectal Neoplasms
- Atezolizumab
- 5-FU based radio-chemotherapy
-
Charleroi, Hainaut, Belgium
- +4 more
Dec 14, 2022
Cholangiocarcinoma, Liver Cancer Trial in Houston (Infigratinib, Atezolizumab, Bevacizumab)
Not yet recruiting
- Cholangiocarcinoma
- Liver Cancer
- Infigratinib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Metastatic Colorectal Cancer Trial in Pisa (Bevacizumab, Irinotecan, Oxaliplatin)
Active, not recruiting
- Metastatic Colorectal Cancer
- Bevacizumab
- +5 more
-
Pisa, Italia, ItalyFrancesca Vannini
Jan 4, 2023
Metastatic or Locally Advanced Malignancies Trial in Germany (Vemurafenib, Cobimetinib, Atezolizumab)
Recruiting
- Metastatic or Locally Advanced Malignancies
- Vemurafenib
- +7 more
-
Berlin, Germany
- +5 more
Jan 2, 2023
Breast Cancer Trial in Barcelona, Madrid, Valencia (Talimogene laherparepvec, Atezolizumab)
Active, not recruiting
- Breast Cancer
- Talimogene laherparepvec
- Atezolizumab
-
Barcelona, Spain
- +3 more
Sep 27, 2022
NSCLC Metastatic Trial (Atezolizumab, Nab paclitaxel, Carboplatin)
Not yet recruiting
- Non-Small Cell Lung Cancer Metastatic
- Atezolizumab
- +5 more
- (no location specified)
Jan 18, 2023
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Seattle
Not yet recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +2 more
- Atezolizumab
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 6, 2023
Prostate Adenocarcinoma, Prostate Cancer, Localized Prostate Cancer Trial in San Francisco, Saint Louis (Atezolizumab,
Recruiting
- Prostate Adenocarcinoma
- +2 more
- Atezolizumab
- +2 more
-
San Francisco, California
- +1 more
Oct 8, 2022
Triple Negative Breast Cancer Trial in London (Atezolizumab, Ipatasertib, Paclitaxel)
Active, not recruiting
- Triple Negative Breast Cancer
- Atezolizumab
- +4 more
-
London, United KingdomBarts Health NHS Trust
Aug 10, 2022
BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in
Withdrawn
- BCLC Stage B Hepatocellular Carcinoma
- +4 more
- Atezolizumab
- +3 more
- (no location specified)
Dec 12, 2022